RecruitingNCT00114647

Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies

Procedures to Obtain Plasma, Lymphocytes, or Other Specimens for Research Studies


Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment

3,000 participants

Start Date

Jan 9, 1984

Study Type

OBSERVATIONAL

Conditions

Summary

This study will collect blood plasma and white blood cells from individuals using a procedure called apheresis. Apheresis is a method of collecting larger quantities of certain blood components that can safely be collected through a simple blood draw. The blood components will be used in laboratory research studies. Patients 18 years of age and older who are currently enrolled in a NIH clinical research protocol may participate in this study. Relatives of patients and normal healthy volunteers will also be enrolled. Individuals will undergo one of the following two apheresis procedures: * Automated pheresis Blood is drawn through a needle placed in an arm vein and circulated through a cell separator machine. The plasma (liquid part of the blood) and white cells are extracted, and the red cells are re-infused into the donor through the same needle or a needle in the other arm. An anticoagulant (medication to prevent blood from clotting) is usually added to the blood while in the machine to prevent it from clotting during processing. * Manual pheresis One unit (1 pint) of blood is drawn through a needle placed in an arm vein, similar to donating a pint of whole blood. The red blood cells, with or without plasma, are separated from the rest of the blood and returned to the donor through the same needle. Manual pheresis will be done only when a person s estimated total blood volume or red cell count is too low to safely permit removal of blood through a pheresis machine. An adult small in size or markedly anemic, for example, may fall into this category. Some of the blood collected through apheresis may be stored for future studies of HIV disease and immune function and for HLA testing, a genetic test of markers of the immune system. Some of the blood may be used to screen for different types of viral liver infections, such as hepatitis A, B, C, D, E, F, or G.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study collects blood plasma and immune cells from volunteers — both with and without HIV or inflammatory conditions — through a blood filtering procedure (apheresis) to support laboratory research. **You may be eligible if...** - You are 18 years of age or older - You have adequate vein access and acceptable blood counts and blood pressure - You are willing to consent to blood collection, hepatitis screening, and genetic testing (including HLA typing) **You may NOT be eligible if...** - You are pregnant or breastfeeding - You are currently misusing alcohol or drugs - You have a medical condition that the study doctor believes makes the blood collection procedure unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00114647


Related Trials